EcoDrugPlus

Tachykinin Receptor 2

Ensembl ID : ENSMLUG00000012713
Gene Symbol: TACR2
4 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMLUG00000015733
Gene Symbol: TACR3
2 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMLUG00000012533
Gene Symbol: TERT
2 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSMLUG00000017164
Gene Symbol: TBXAS1
2 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSMLUG00000003517
Gene Symbol: TBXA2R
2 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSMLUG00000010651
Gene Symbol: TYMP
2 Cross references
173 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSMLUG00000009587
Gene Symbol: TYMS
2 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMLUG00000009632
Gene Symbol: THRB
2 Cross references
392 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSMLUG00000012813
Gene Symbol: TLR2
4 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSMLUG00000007417
Gene Symbol: TLR4
2 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSMLUG00000003912
Gene Symbol: TLR7
4 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSMLUG00000012745
Gene Symbol: TLR8
2 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).